Rock Springs Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-200,000
Closed -$7.16M 126
2023
Q2
$7.16M Hold
200,000
0.17% 83
2023
Q1
$4.69M Hold
200,000
0.11% 88
2022
Q4
$5.44M Hold
200,000
0.13% 86
2022
Q3
$10.8M Hold
200,000
0.28% 76
2022
Q2
$8.07M Hold
200,000
0.23% 85
2022
Q1
$13.2M Hold
200,000
0.33% 75
2021
Q4
$20M Hold
200,000
0.46% 65
2021
Q3
$25M Hold
200,000
0.53% 62
2021
Q2
$24.8M Hold
200,000
0.49% 66
2021
Q1
$30.5M Hold
200,000
0.67% 50
2020
Q4
$25.8M Buy
200,000
+10,000
+5% +$1.15M 0.55% 63
2020
Q3
$21.2M Hold
190,000
0.54% 60
2020
Q2
$15.4M Hold
190,000
0.42% 79
2020
Q1
$13.2M Hold
190,000
0.55% 61
2019
Q4
$14.8M Hold
190,000
0.47% 73
2019
Q3
$12.1M Hold
190,000
0.48% 65
2019
Q2
$16.4M Buy
190,000
+10,000
+6% +$764K 0.59% 62
2019
Q1
$13.8M Sell
180,000
-36,000
-17% -$2M 0.53% 62
2018
Q4
$8.12M Buy
+216,000
New +$7.96M 0.38% 79

Other funds holding GH

Rock Springs Capital Management's GH Position: Q3 2023 in Review

Rock Springs Capital Management sold out of Guardant Health (GH) in Q3 2023, closing a stake of 200,000 shares — an estimated $7.16M sold.

Rock Springs Capital Management first reported a position in GH in Q4 2018 and held it in 19 quarters. The position peaked at $30.5M in Q1 2021. 296 funds tracked by Wall St. Rank hold GH as of Q3 2023.

  • Rock Springs Capital Management reported no remaining Guardant Health position as of Q3 2023 after selling out during the quarter.
  • Rock Springs Capital Management sold 200,000 Guardant Health shares in Q3 2023, an estimated $7.16M.
  • Rock Springs Capital Management first reported a position in Guardant Health in Q4 2018 and held it in 19 quarters.
  • Rock Springs Capital Management's Guardant Health position peaked at $30.5M in Q1 2021.
  • 296 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on Rock Springs Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.